Cargando…
The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times
Approximately 30–50% of hereditary breast and ovarian cancer (HBOC) is due to the presence of germline pathogenic variants in the BRCA1 (OMIM 113705) and BRCA2 (OMIM 600185) onco-suppressor genes, which are involved in DNA damage response. Women who carry pathogenic BRCA1 variants are particularly l...
Autores principales: | Aretini, Paolo, Presciuttini, Silvano, Pastore, Aldo, Galli, Alvaro, Panepinto, Sara, Tancredi, Mariella, Ghilli, Matteo, Guglielmi, Chiara, Sidoti, Diletta, Congregati, Caterina, Caligo, Maria Adelaide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648645/ https://www.ncbi.nlm.nih.gov/pubmed/37958491 http://dx.doi.org/10.3390/ijms242115507 |
Ejemplares similares
-
Validation and Data-Integration of Yeast-Based Assays for Functional Classification of BRCA1 Missense Variants
por: Bellè, Francesca, et al.
Publicado: (2022) -
Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations
por: GAMBINO, GAETANA, et al.
Publicado: (2015) -
Functional Interaction Between BRCA1 and DNA Repair in Yeast May Uncover a Role of RAD50, RAD51, MRE11A, and MSH6 Somatic Variants in Cancer Development
por: Maresca, Luisa, et al.
Publicado: (2018) -
Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1
por: Caleca, Laura, et al.
Publicado: (2014) -
Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions
por: Guglielmi, Chiara, et al.
Publicado: (2021)